BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34797687)

  • 1. Contrast-enhanced ultrasound-based ultrasomics score: a potential biomarker for predicting early recurrence of hepatocellular carcinoma after resection or ablation.
    Huang H; Ruan SM; Xian MF; Li MD; Cheng MQ; Li W; Huang Y; Xie XY; Lu MD; Kuang M; Wang W; Hu HT; Chen LD
    Br J Radiol; 2022 Feb; 95(1130):20210748. PubMed ID: 34797687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Value of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Early Recurrence of Hepatocellular Carcinoma after Surgical Resection.
    Wang Y; Liao J; Qi W; Xie L; Li Y
    Ultrasound Med Biol; 2016 May; 42(5):1042-8. PubMed ID: 26803390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic Contrast-Enhanced Ultrasound Radiomics for Hepatocellular Carcinoma Recurrence Prediction After Thermal Ablation.
    Ma QP; He XL; Li K; Wang JF; Zeng QJ; Xu EJ; He XQ; Li SY; Kun W; Zheng RQ; Tian J
    Mol Imaging Biol; 2021 Aug; 23(4):572-585. PubMed ID: 33483803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Pathological Grading of Hepatocellular Carcinoma Using Ultrasomics of Contrast-Enhanced Ultrasound.
    Wang W; Wu SS; Zhang JC; Xian MF; Huang H; Li W; Zhou ZM; Zhang CQ; Wu TF; Li X; Xu M; Xie XY; Kuang M; Lu MD; Hu HT
    Acad Radiol; 2021 Aug; 28(8):1094-1101. PubMed ID: 32622746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation.
    Shan QY; Hu HT; Feng ST; Peng ZP; Chen SL; Zhou Q; Li X; Xie XY; Lu MD; Wang W; Kuang M
    Cancer Imaging; 2019 Feb; 19(1):11. PubMed ID: 30813956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumour cell counts and ultrasomics signature-based nomogram for preoperative prediction of early recurrence of hepatocellular carcinoma after radical treatment.
    Li W; Zhuang BW; Qiao B; Zhang N; Hu HT; Li C; Xie XH; Kuang M; Lu MD; Xie XY; Wang W
    Br J Radiol; 2022 Oct; 95(1139):20211137. PubMed ID: 36165329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-Enhanced Ultrasound to Monitor Early Recurrence of Primary Hepatocellular Carcinoma after Curative Treatment.
    Liu LF; Ding ZL; Zhong JH; Li HX; Liu JJ; Li H; Li LQ
    Biomed Res Int; 2018; 2018():8910562. PubMed ID: 30533441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation between combined hepatocellular carcinoma and hepatocellular carcinoma: comparison of diagnostic performance between ultrasomics-based model and CEUS LI-RADS v2017.
    Li CQ; Zheng X; Guo HL; Cheng MQ; Huang Y; Xie XY; Lu MD; Kuang M; Wang W; Chen LD
    BMC Med Imaging; 2022 Mar; 22(1):36. PubMed ID: 35241004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Value of Contrast-enhanced Ultrasound for Early Recurrence of Single Lesion Hepatocellular Carcinoma After Curative Resection.
    Xiachuan Q; Xiang Z; Xuebing L; Yan L
    Ultrason Imaging; 2019 Jan; 41(1):49-58. PubMed ID: 30803409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation.
    Gao Y; Zheng DY; Cui Z; Ma Y; Liu YZ; Zhang W
    World J Gastroenterol; 2015 Sep; 21(36):10418-26. PubMed ID: 26420968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine Learning-Based Ultrasomics Improves the Diagnostic Performance in Differentiating Focal Nodular Hyperplasia and Atypical Hepatocellular Carcinoma.
    Li W; Lv XZ; Zheng X; Ruan SM; Hu HT; Chen LD; Huang Y; Li X; Zhang CQ; Xie XY; Kuang M; Lu MD; Zhuang BW; Wang W
    Front Oncol; 2021; 11():544979. PubMed ID: 33842303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative prediction of pathological grading of hepatocellular carcinoma using machine learning-based ultrasomics: A multicenter study.
    Ren S; Qi Q; Liu S; Duan S; Mao B; Chang Z; Zhang Y; Wang S; Zhang L
    Eur J Radiol; 2021 Oct; 143():109891. PubMed ID: 34481117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma.
    Zhou Y; He L; Huang Y; Chen S; Wu P; Ye W; Liu Z; Liang C
    Abdom Radiol (NY); 2017 Jun; 42(6):1695-1704. PubMed ID: 28180924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of contrast-enhanced ultrasound washout rate in predicting hepatocellular carcinoma differentiation.
    Feng Y; Qin XC; Luo Y; Li YZ; Zhou X
    Ultrasound Med Biol; 2015 Jun; 41(6):1553-60. PubMed ID: 25747937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive Prediction of Ki-67 Expression in Hepatocellular Carcinoma Using Machine Learning-Based Ultrasomics: A Multicenter Study.
    Zhang L; Duan S; Qi Q; Li Q; Ren S; Liu S; Mao B; Zhang Y; Wang S; Yang L; Liu R; Liu L; Li Y; Li N; Zhang L
    J Ultrasound Med; 2023 May; 42(5):1113-1122. PubMed ID: 36412932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography.
    Shiozawa K; Watanabe M; Takayama R; Takahashi M; Wakui N; Iida K; Sumino Y
    J Clin Ultrasound; 2010 May; 38(4):182-9. PubMed ID: 20232404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative dynamic contrast-enhanced ultrasound to predict intrahepatic recurrence of hepatocellular carcinoma after radiofrequency ablation: a cohort study.
    Han X; Dong J; Liu Z; Wu B; Tian Y; Tan H; Cheng W
    Int J Hyperthermia; 2020; 37(1):1066-1073. PubMed ID: 32924654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irregular Defects in Hepatocellular Carcinomas During the Kupffer Phase of Contrast-Enhanced Ultrasonography with Perfluorobutane Microbubbles: Pathological Features and Metastatic Recurrence After Surgical Resection.
    Nuta J; Shingaki N; Ida Y; Shimizu R; Hayami S; Ueno M; Fukatsu K; Itonaga M; Yoshida T; Maeda Y; Moribata K; Deguchi H; Maekita T; Iguchi M; Kato J; Yamaue H; Tamai H
    Ultrasound Med Biol; 2017 Sep; 43(9):1829-1836. PubMed ID: 28625558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MR imaging can predict early recurrence after curative resection using image features and texture analysis.
    Ahn SJ; Kim JH; Park SJ; Kim ST; Han JK
    Abdom Radiol (NY); 2019 Feb; 44(2):539-548. PubMed ID: 30229421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic efficacy of contrast-enhanced ultrasound versus MRI Liver Imaging Reporting and Data System (LI-RADS) for categorising hepatic observations in patients at risk of hepatocellular carcinoma.
    Li S; Zhou L; Chen R; Chen Y; Niu Z; Qian L; Fang Y; Xu L; Xu H; Zhang L
    Clin Radiol; 2021 Feb; 76(2):161.e1-161.e10. PubMed ID: 33198943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.